Tzvi Dwolatzky

Prof. Dr. Tzvi Dwolatzky

Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Public Health
Verified
Journal Article
Closed access
NDN. Douthit
N. Douthit
SKS. Kiv
S. Kiv
Tzvi DwolatzkyTzvi Dwolatzky
Tzvi Dwolatzky
SBS. Biswas
S. Biswas

2 November 2003 in BMC Geriatrics
Verified
Journal Article
Open access
Tzvi DwolatzkyTzvi Dwolatzky
Tzvi Dwolatzky
VWVictor Whitehead
Victor Whitehead
Glen M DonigerGlen M Doniger
Glen M Doniger
ESEly S Simon
Ely S Simon
ASAvraham Schweiger
Avraham Schweiger
HCHoward Chertkow
Howard Chertkow
The NeuroTrax Mindstreams computerized cognitive assessment system was designed for widespread clinical and research use in detecting mild cognitive impairment (MCI). However, the capability of Mindstreams tests to discriminate elderly with MCI from those who are cognitively healthy has yet to be evaluated. Moreover, the comparability between these tests and traditional neuropsychological tests in detecting MCI has not been examined. A 2-center study was designed to assess discriminant validity of tests in the Mindstreams Mild Impairment Battery. Participants were 30 individuals diagnosed with MCI, 29 with mild Alzheimer's disease (AD), and 39 healthy elderly. Testing was with the Mindstreams battery and traditional neuropsychological tests. Receiver operating characteristic (ROC) analysis was used to examine the ability of Mindstreams and traditional measures to discriminate those with MCI from cognitively healthy elderly. Between-group comparisons were made (Mann-Whitney U test) between MCI and healthy elderly and between MCI and mild AD groups. Mindstreams outcome parameters across multiple cognitive domains significantly discriminated among MCI and healthy elderly with considerable effect sizes (p < 0.05). Measures of memory, executive function, visual spatial skills, and verbal fluency discriminated best, and discriminability was at least comparable to that of traditional neuropsychological tests in these domains. Mindstreams tests are effective in detecting MCI, providing a comprehensive profile of cognitive function. Further, the enhanced precision and ease of use of these computerized tests make the NeuroTrax system a valuable clinical tool in the identification of elderly at high risk for dementia.

1 December 2001 in Clinical Nutrition
Verified
Journal Article
Closed access
Tzvi DwolatzkyTzvi Dwolatzky
Tzvi Dwolatzky
SBS. Berezovski
S. Berezovski
RFR. Friedmann
R. Friedmann
JPJ. Paz
J. Paz
ACA.M. Clarfield
A.M. Clarfield
MSM. Sonnenblick
M. Sonnenblick

1 June 2017 in The Lancet
Verified
Journal Article
Closed access
Tzvi DwolatzkyTzvi Dwolatzky
Tzvi Dwolatzky
JBJenny Brodsky
Jenny Brodsky
FAFaisal Azaiza
Faisal Azaiza
ACA Mark Clarfield
A Mark Clarfield
JJJeremy M Jacobs
Jeremy M Jacobs
HLHoward Litwin
Howard Litwin

1 September 2012 in Journal of Geriatric Psychiatry and Neurology
Verified
Journal Article
Closed access
MLMichal Lifshitz
Michal Lifshitz
Tzvi DwolatzkyTzvi Dwolatzky
Tzvi Dwolatzky
YPYan Press
Yan Press
Introduction: The English version of the Montreal Cognitive Assessment (MoCA) test has been shown to be reliable in screening for mild cognitive impairment (MCI). However, the sensitivity and specificity of the Hebrew version of this instrument are yet to be determined. Methods: The study population consisted of 2 groups of older individuals, 74 patients diagnosed with MCI and 80 patients who were cognitively asymptomatic. Cognitive evaluation included the Mini-Mental State Examination (MMSE), Mindstreams computerized cognitive assessment, and the MoCA test. Results: The Hebrew version of MoCA distinguished between cognitively asymptomatic older individuals and those with MCI, with a sensitivity of 94.6% and a specificity of 76.3%, using a cutoff of 26/30 points. Conclusions: The Hebrew version of the MoCA test is effective for identifying MCI in older patients. As a screening instrument for MCI, its higher sensitivity makes it preferable o the MMSE, which is used extensively in the clinical setting.

1 January 2006 in American Journal of Alzheimer's Disease and Other Dementias®
Verified
Journal Article
Closed access
Glen M DonigerGlen M Doniger
Glen M Doniger
Tzvi DwolatzkyTzvi Dwolatzky
Tzvi Dwolatzky
DZDavid M. Zucker
David M. Zucker
HCHoward Chertkow
Howard Chertkow
HCHoward Crystal
Howard Crystal
ESEly S. Simon
Ely S. Simon
Cognitive and depressive symptoms co-occur, complicating detection of mild cognitive impairment (MCI) and early dementia. In this study, discriminant validity of a novel computerized cognitive battery for MCI detection was evaluated after covariation for depressive symptom severity. In addition to the computerized battery, participants at two sites received the 30-item self-administered Geriatric Depression Scale (GDS; n = 72); those at two other centers received the observer-administered Cornell Scale for Depression in Dementia (CSDD; n = 88). In both cohorts, a Global Cognitive Score and memory, executive function, visual spatial, and verbal index scores discriminated among cognitively healthy, MCI, and mild dementia groups after covariation for GDS or CSDD, respectively (p < 0.05). Thus, the computerized battery for detection of mild impairment is robust to comorbid depressive symptoms, supporting its clinical utility in identifying neurodegenerative disease even in elderly with depression.